【24h】

Degradation study of irbesartan: Isolation and structural elucidation of novel degradants

机译:厄贝沙坦的降解研究:新型降解剂的分离和结构阐明

获取原文
获取原文并翻译 | 示例
           

摘要

To assess the stability of Irbesartan under stress conditions, and identify the degradation products, it was subjected to hydrolytic and oxidative stress, according to ICH guideline Q1A (R2). The drug showed degradation only in basic conditions, while it was stable to other stress conditions. Three degradation products were formed, which were separated on a C-8 column employing prep HPLC using gradient elution. The structures were established by extensive 1D and 2D NMR spectroscopic studies and mass spectra. The products were identified as (2′-(2H-tetrazol-5-yl)-[1,1′-biphenyl]-4-yl)methanamine (DP-1),N-((2′-(2H-tetrazol-5-yl)-[1,1′-biphenyl]-4-yl)methyl)pentanamide (DP-2) andN-((2′-(2H-tetrazol-5-yl)-[1,1′-biphenyl]-4-yl)methyl)-1-pentanamidocyclopentane-1-carboxamide (DP-3). One of the three, DP-1, was reported earlier. However, its structure has not been elucidated by NMR. The other two degradants are novel and are being reported here for the first time.
机译:为了评估厄贝沙坦在应力条件下的稳定性,并鉴定降解产物,根据ICH指南Q1A(R2),对其进行水解和氧化应激。 该药物仅在基本条件下出现降解,而其对其他压力条件稳定。 形成三种降解产物,在使用梯度洗脱的使用制备HPLC的C-8柱上分离。 通过广泛的1D和2D NMR光谱研究和质谱建立了结构。 将产物鉴定为(2' - (2H-四唑-5-基) - [1,1'-Biphenyl] -4-基)甲烷胺(DP-1),N - ((2' - (2H-四唑) -5-基) - [1,1'-Biphenyl] -4-基)甲基)戊烷酰胺(DP-2)AndN - ((2' - (2'-(2H-四唑-5-基) - [1,1' - 联苯] -4-基)甲基)-1-戊烷脒环戊烷-1-甲酰胺(DP-3)。 早先报道了三个DP-1中的一个。 然而,其结构尚未通过NMR阐明。 另外两种降低剂是新颖的,并在这里首次报道。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号